Versigent (NYSE:VGNT – Get Free Report) Director Kevin Clark sold 74,130 shares of Versigent stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the transaction, the director owned 124,849 shares of the company’s stock, valued at $5,701,853.83. The trade was a 37.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Versigent Stock Up 1.2%
NYSE:VGNT opened at $46.98 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29. The company has a 50 day simple moving average of $44.42. The company has a market capitalization of $3.33 billion and a price-to-earnings ratio of 24.47. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88.
Versigent (NYSE:VGNT – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.34. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.29 billion. Equities research analysts expect that Versigent will post 7.23 EPS for the current year.
Versigent Dividend Announcement
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC bought a new stake in shares of Versigent in the second quarter valued at about $57,000. Sequoia Financial Advisors LLC acquired a new position in shares of Versigent in the second quarter valued at about $220,000. Kintegral Advisory LLC bought a new position in Versigent during the second quarter worth about $224,000. Engineers Gate Manager LP bought a new position in Versigent during the second quarter worth about $418,000. Finally, Corient Private Wealth LP acquired a new stake in Versigent in the 2nd quarter worth about $426,000.
Wall Street Analyst Weigh In
Several research firms have commented on VGNT. Argus upped their price objective on shares of Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a report on Thursday, August 13th. Zacks Research cut shares of Versigent from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Wells Fargo & Company lifted their target price on shares of Versigent from $48.00 to $56.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $54.00 price target on shares of Versigent in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada upgraded shares of Versigent from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $41.00 to $52.00 in a research report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $54.00.
Get Our Latest Analysis on Versigent
Versigent Company Profile
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Read More
- Five stocks we like better than Versigent
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
